WallStreetZenWallStreetZen

NASDAQ: RPTX
Repare Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Repare Therapeutics earnings were -$84.7M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest RPTX earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$28.7M, down 16.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, RPTX reported annual earnings of -$84.7M, with -9.7% growth.

RPTX earnings history

Current Revenue
$53.5M
Current Earnings
-$84.7M
Current Profit Margin
-158.4%

RPTX Return on Equity

Current Company
-44.5%
Current Industry
-2%
Current Market
34.1%
RPTX's Return on Equity (-44.5%)... subscribe to Premium to read more.
High Return on Equity Performance

RPTX undefined

Current Company
-38.4%
Current Industry
-0.4%
RPTX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when RPTX announces earnings.

RPTX undefined

Current Company
-55.05%
Current Industry
5.9%
RPTX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

RPTX vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
RPTX-$78.97M-$84.69MN/A-$2.00
APLT-$105.20M-$105.62MN/A-$0.76
PMVP-$73.91M-$58.71MN/A-$1.14
SKYE-$25.51M-$26.57MN/A-$0.73
DTIL$13.53M$7.17MN/A$1.05
View Top Biotech Stocks

Repare Therapeutics Earnings Reports & History FAQ

What were Repare Therapeutics's earnings last quarter?

Repare Therapeutics (NASDAQ: RPTX) reported Q4 2024 earnings per share (EPS) of -$0.68, up 1.49% year over year. Total RPTX earnings for the quarter were -$28.67 million. In the same quarter last year, Repare Therapeutics's earnings per share (EPS) was -$0.67.

If you're new to stock investing, here's how to buy Repare Therapeutics stock.

Is Repare Therapeutics profitable or losing money?

As of the last Repare Therapeutics earnings report, Repare Therapeutics is currently losing money. Repare Therapeutics's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$84.69 million, a 9.71% decrease year over year.

What was RPTX's earnings growth in the past year?

As of Repare Therapeutics's earnings date in Q2 2025, Repare Therapeutics's earnings has grown year over year. RPTX earnings in the past year totalled -$84.69 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.